AU2019902698A0 - Methods and compositions - Google Patents

Methods and compositions

Info

Publication number
AU2019902698A0
AU2019902698A0 AU2019902698A AU2019902698A AU2019902698A0 AU 2019902698 A0 AU2019902698 A0 AU 2019902698A0 AU 2019902698 A AU2019902698 A AU 2019902698A AU 2019902698 A AU2019902698 A AU 2019902698A AU 2019902698 A0 AU2019902698 A0 AU 2019902698A0
Authority
AU
Australia
Prior art keywords
compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2019902698A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Melbourne
Original Assignee
University of Melbourne
Filing date
Publication date
Application filed by University of Melbourne filed Critical University of Melbourne
Publication of AU2019902698A0 publication Critical patent/AU2019902698A0/en
Priority to PCT/AU2020/050145 priority Critical patent/WO2021016652A1/en
Abandoned legal-status Critical Current

Links

AU2019902698A 2019-07-29 2019-07-29 Methods and compositions Abandoned AU2019902698A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2020/050145 WO2021016652A1 (en) 2019-07-29 2020-02-20 METHODS AND COMPOSITIONS FOR MONITORING, TREATING AND PREVENTING CMV INFECTION OR GRAFT REJECTION USING γδ T-CELLS

Publications (1)

Publication Number Publication Date
AU2019902698A0 true AU2019902698A0 (en) 2019-08-15

Family

ID=

Similar Documents

Publication Publication Date Title
EP3823673A4 (en) Anti-cd112r compositions and methods
EP3917497A4 (en) Oligonucleotide compositions and methods thereof
EP3600325A4 (en) Novel compositions and methods
EP3790861A4 (en) Senolytic compositions and uses thereof
EP3843729A4 (en) Novel compositions and methods
EP3844500A4 (en) Rp182 compositions and methods
EP4037711A4 (en) Compositions and methods comprising anti-nrp2 antibodies
EP3790557A4 (en) Compositions and methods for improving strand biased
EP3897615A4 (en) Cannabis compositions and methods
EP4051017A4 (en) Probiotic compositions and methods
EP4037709A4 (en) Knottin-immunostimulant conjugates and related compositions and methods
EP3962512A4 (en) Immunomodulatory compositions and methods
EP3921335A4 (en) Compositions and methods involving layilin
EP3927372A4 (en) Optimized vaccine compositions and methods for making the same
EP3818245A4 (en) Cement compositions and methods
EP3917320A4 (en) Bacterialcidal methods and compositions
EP4003936A4 (en) Whitening methods and compositions
EP3920702A4 (en) Pesticidal compositions and methods
EP3919612A4 (en) Composition and application thereof
EP3856184A4 (en) Compositions and methods for inhibiting acss2
AU2019904455A0 (en) Compositions and methods
AU2019902698A0 (en) Methods and compositions
AU2019901465A0 (en) Compositions and methods
TWI859319B (en) Anti-cd73 antibodies and compositions
AU2018902624A0 (en) Methods and compositions